Shandong Weigao Group Medical Polymer Co (HK:1066) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts and uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Shandong Weigao Group Medical Polymer Co. reported a decrease in unaudited revenue by 3.8% and net profit by 7.5% for the first half of 2024 compared to the same period in the previous year. Despite the downturn, the company has proposed an increased interim dividend of RMB0.0919 per share, up from RMB0.0734 per share in 2023, pending shareholder approval.
For further insights into HK:1066 stock, check out TipRanks’ Stock Analysis page.
